ClinicalTrials.Veeva

Menu

Addition of Silver Nanoparticles to a Orthodontic Primer in Preventing Enamel Demineralization Adjacent Brackets

U

Universidad Autonoma de San Luis Potosí

Status and phase

Unknown
Phase 3

Conditions

Tooth Demineralization

Treatments

Other: Placebo
Other: Silver nanoparticles

Study type

Interventional

Funder types

Other

Identifiers

NCT02400957
CEI-FE-023-013

Details and patient eligibility

About

Evaluate the effectiveness of silver nanoparticles incorporated into the primer orthodontic Transbond XT in preventing enamel demineralization adjacent to brackets.

Full description

Randomized, split mouth, double-blind, placebo controlled trial. Half of the mouth was applied silver nanoparticles incorporated into the primer orthodontic Transbond XT and the other half with primer-bond as placebo. Evaluate the effectiveness with Diagnodent - pen in preventing enamel demineralization adjacent to brackets.

Enrollment

40 estimated patients

Sex

All

Ages

10 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients candidates for orthodontic treatment.

Exclusion criteria

  • Patients with O.D 11 and / or 21 absent.

    • Patients who present dentures of any kind in OD 11 and 21.
    • Patients presenting endodontic OD 11 and 21.
    • Patients presenting data gingivitis day cementing brackets.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Silver nanoparticles
Experimental group
Description:
Half of the mouth was applied silver nanoparticles. Allocation was randomized.
Treatment:
Other: Silver nanoparticles
Placebo
Experimental group
Description:
Half of the mouth was applied placebo. Allocation was randomized.
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems